4116名日本酒精依赖男性的精神合并症史及其与饮酒里程碑、危险药物使用、自杀企图和ADH1B和ALDH2基因型的关系:一项探索性研究

IF 3 Q2 SUBSTANCE ABUSE
Akira Yokoyama, Tetsuji Yokoyama, Yosuke Yumoto, Tsuyoshi Takimura, Tomomi Toyama, Junichi Yoneda, Kotaro Nishimura, Ruriko Minobe, Takanobu Matsuzaki, Mitsuru Kimura, Sachio Matsushita
{"title":"4116名日本酒精依赖男性的精神合并症史及其与饮酒里程碑、危险药物使用、自杀企图和ADH1B和ALDH2基因型的关系:一项探索性研究","authors":"Akira Yokoyama,&nbsp;Tetsuji Yokoyama,&nbsp;Yosuke Yumoto,&nbsp;Tsuyoshi Takimura,&nbsp;Tomomi Toyama,&nbsp;Junichi Yoneda,&nbsp;Kotaro Nishimura,&nbsp;Ruriko Minobe,&nbsp;Takanobu Matsuzaki,&nbsp;Mitsuru Kimura,&nbsp;Sachio Matsushita","doi":"10.1111/acer.70014","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Alcohol dependence (AD) is often comorbid with other mental disorders. We assessed how comorbidities are associated with the clinical features of AD.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Information on the history of mental comorbidities, hazardous drug use, suicide attempts, and drinking milestones was collected on a semi-structured medical history form from 4116 Japanese male AD inpatients (2007–2018); the subjects' <i>ADH1B</i> and <i>ALDH2</i> genotypes (rs1229984/rs671) were also determined.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the total, 889 (21.60%) patients reported a history of mental comorbidities, including mood disorders (15.48%) and insomnia (2.89%); 202 (4.91%) reported a history of hazardous drug use, and 614 (14.92%) reported suicide attempts. Comorbidities were most commonly diagnosed around the time of onset of advanced alcohol use disorder (aAUD). Patients with comorbidities who began drinking regularly showed more rapid progression to aAUD and to the start of treatment for AD. Multivariate odds ratios (MORs [95%CI]) for the fast-metabolizing <i>ADH1B*1/*2</i> and <i>ADH1B*2/*2</i>, protective against AD, were higher in patients with comorbidities [1.43 (1.16–1.76) and 1.35 (1.11–1.66)], drug use [1.64 (1.09–2.46) and 1.60 (1.07–2.38)], and suicide attempts [1.45 (1.13–1.85) and 1.49 (1.17–1.88)] compared with the <i>ADH1B*1/*1</i>. MORs for the inactive protective <i>ALDH2*1/*2</i> were increased only in patients with insomnia [2.65 (1.75–4.02)] compared with the <i>ALDH2*1/*1</i>. MORs for smoking [0.74 (0.58–0.94)] and for age ≤15 years at first drink [0.66 (0.54–0.81)] were lower in patients with comorbidities. MORs for suicide attempts were 2.87 (2.36–3.48) in patients with comorbidities and 3.38 (2.47–4.62) in patients with drug use.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Mental comorbidities and a history of suicide attempts were frequent in Japanese patients with AD. Risk factors for AD (<i>ADH1B*1/*1</i>, smoking, early initiation of drinking) were negatively associated with the risk of comorbidities, suggesting interactions between comorbidities and AD risk factors. Insomnia was positively associated with the inactive <i>ALDH2*1/*2</i>. AD patients with mental comorbidities require multifaceted interventions, including suicide prevention.</p>\n </section>\n </div>","PeriodicalId":72145,"journal":{"name":"Alcohol (Hanover, York County, Pa.)","volume":"49 4","pages":"804-817"},"PeriodicalIF":3.0000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"History of mental comorbidities and their relationships with drinking milestones, hazardous drug use, suicide attempts, and the ADH1B and ALDH2 genotypes in 4116 Japanese men with alcohol dependence: An exploratory study\",\"authors\":\"Akira Yokoyama,&nbsp;Tetsuji Yokoyama,&nbsp;Yosuke Yumoto,&nbsp;Tsuyoshi Takimura,&nbsp;Tomomi Toyama,&nbsp;Junichi Yoneda,&nbsp;Kotaro Nishimura,&nbsp;Ruriko Minobe,&nbsp;Takanobu Matsuzaki,&nbsp;Mitsuru Kimura,&nbsp;Sachio Matsushita\",\"doi\":\"10.1111/acer.70014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Alcohol dependence (AD) is often comorbid with other mental disorders. We assessed how comorbidities are associated with the clinical features of AD.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Information on the history of mental comorbidities, hazardous drug use, suicide attempts, and drinking milestones was collected on a semi-structured medical history form from 4116 Japanese male AD inpatients (2007–2018); the subjects' <i>ADH1B</i> and <i>ALDH2</i> genotypes (rs1229984/rs671) were also determined.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Of the total, 889 (21.60%) patients reported a history of mental comorbidities, including mood disorders (15.48%) and insomnia (2.89%); 202 (4.91%) reported a history of hazardous drug use, and 614 (14.92%) reported suicide attempts. Comorbidities were most commonly diagnosed around the time of onset of advanced alcohol use disorder (aAUD). Patients with comorbidities who began drinking regularly showed more rapid progression to aAUD and to the start of treatment for AD. Multivariate odds ratios (MORs [95%CI]) for the fast-metabolizing <i>ADH1B*1/*2</i> and <i>ADH1B*2/*2</i>, protective against AD, were higher in patients with comorbidities [1.43 (1.16–1.76) and 1.35 (1.11–1.66)], drug use [1.64 (1.09–2.46) and 1.60 (1.07–2.38)], and suicide attempts [1.45 (1.13–1.85) and 1.49 (1.17–1.88)] compared with the <i>ADH1B*1/*1</i>. MORs for the inactive protective <i>ALDH2*1/*2</i> were increased only in patients with insomnia [2.65 (1.75–4.02)] compared with the <i>ALDH2*1/*1</i>. MORs for smoking [0.74 (0.58–0.94)] and for age ≤15 years at first drink [0.66 (0.54–0.81)] were lower in patients with comorbidities. MORs for suicide attempts were 2.87 (2.36–3.48) in patients with comorbidities and 3.38 (2.47–4.62) in patients with drug use.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Mental comorbidities and a history of suicide attempts were frequent in Japanese patients with AD. Risk factors for AD (<i>ADH1B*1/*1</i>, smoking, early initiation of drinking) were negatively associated with the risk of comorbidities, suggesting interactions between comorbidities and AD risk factors. Insomnia was positively associated with the inactive <i>ALDH2*1/*2</i>. AD patients with mental comorbidities require multifaceted interventions, including suicide prevention.</p>\\n </section>\\n </div>\",\"PeriodicalId\":72145,\"journal\":{\"name\":\"Alcohol (Hanover, York County, Pa.)\",\"volume\":\"49 4\",\"pages\":\"804-817\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcohol (Hanover, York County, Pa.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/acer.70014\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcohol (Hanover, York County, Pa.)","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/acer.70014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

摘要

背景:酒精依赖(AD)常与其他精神障碍合并症。我们评估了合并症与AD临床特征的关系。方法:收集4116名日本男性AD住院患者(2007-2018)的精神合并症、危险药物使用、自杀企图和饮酒里程碑的半结构化病史表信息;同时测定受试者ADH1B和ALDH2基因型(rs1229984/rs671)。结果:889例(21.60%)患者有精神合并症史,包括情绪障碍(15.48%)和失眠(2.89%);202人(4.91%)报告有危险药物使用史,614人(14.92%)报告有自杀企图。合并症最常见于晚期酒精使用障碍(aAUD)发病时。有合并症的患者如果开始定期饮酒,则会更快地发展为aAUD和开始治疗AD。与ADH1B*1/*1相比,ADH1B*1/*2和ADH1B*2/*2对AD具有保护作用的多因素优势比(MORs [95%CI])在有合并症的患者中更高[1.43(1.16-1.76)和1.35(1.11-1.66)],吸毒[1.64(1.09-2.46)和1.60(1.07-2.38)],自杀未遂[1.45(1.13-1.85)和1.49(1.17-1.88)]。与ALDH2*1/*1相比,失活性保护性ALDH2*1/*2的MORs仅在失眠患者中升高[2.65(1.75-4.02)]。吸烟的MORs[0.74(0.58-0.94)]和首次饮酒年龄≤15岁的MORs[0.66(0.54-0.81)]在有合并症的患者中较低。合并症患者的MORs为2.87(2.36-3.48),吸毒患者的MORs为3.38(2.47-4.62)。结论:精神合并症和自杀企图史在日本AD患者中很常见。AD的危险因素(ADH1B*1/*1、吸烟、早期饮酒)与合并症的风险呈负相关,提示合并症与AD危险因素之间存在相互作用。失眠与失活ALDH2*1/*2呈正相关。伴有精神合并症的AD患者需要多方面的干预,包括自杀预防。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

History of mental comorbidities and their relationships with drinking milestones, hazardous drug use, suicide attempts, and the ADH1B and ALDH2 genotypes in 4116 Japanese men with alcohol dependence: An exploratory study

History of mental comorbidities and their relationships with drinking milestones, hazardous drug use, suicide attempts, and the ADH1B and ALDH2 genotypes in 4116 Japanese men with alcohol dependence: An exploratory study

Background

Alcohol dependence (AD) is often comorbid with other mental disorders. We assessed how comorbidities are associated with the clinical features of AD.

Methods

Information on the history of mental comorbidities, hazardous drug use, suicide attempts, and drinking milestones was collected on a semi-structured medical history form from 4116 Japanese male AD inpatients (2007–2018); the subjects' ADH1B and ALDH2 genotypes (rs1229984/rs671) were also determined.

Results

Of the total, 889 (21.60%) patients reported a history of mental comorbidities, including mood disorders (15.48%) and insomnia (2.89%); 202 (4.91%) reported a history of hazardous drug use, and 614 (14.92%) reported suicide attempts. Comorbidities were most commonly diagnosed around the time of onset of advanced alcohol use disorder (aAUD). Patients with comorbidities who began drinking regularly showed more rapid progression to aAUD and to the start of treatment for AD. Multivariate odds ratios (MORs [95%CI]) for the fast-metabolizing ADH1B*1/*2 and ADH1B*2/*2, protective against AD, were higher in patients with comorbidities [1.43 (1.16–1.76) and 1.35 (1.11–1.66)], drug use [1.64 (1.09–2.46) and 1.60 (1.07–2.38)], and suicide attempts [1.45 (1.13–1.85) and 1.49 (1.17–1.88)] compared with the ADH1B*1/*1. MORs for the inactive protective ALDH2*1/*2 were increased only in patients with insomnia [2.65 (1.75–4.02)] compared with the ALDH2*1/*1. MORs for smoking [0.74 (0.58–0.94)] and for age ≤15 years at first drink [0.66 (0.54–0.81)] were lower in patients with comorbidities. MORs for suicide attempts were 2.87 (2.36–3.48) in patients with comorbidities and 3.38 (2.47–4.62) in patients with drug use.

Conclusions

Mental comorbidities and a history of suicide attempts were frequent in Japanese patients with AD. Risk factors for AD (ADH1B*1/*1, smoking, early initiation of drinking) were negatively associated with the risk of comorbidities, suggesting interactions between comorbidities and AD risk factors. Insomnia was positively associated with the inactive ALDH2*1/*2. AD patients with mental comorbidities require multifaceted interventions, including suicide prevention.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信